It’s time to renew our global commitment to the fight against HIV. HIV testing has declined 22% compared to pre-pandemic levels. The COVID-19 pandemic has disrupted HIV testing around the world and threatens to reverse the progress gained over the past three decades as many HIV testing and treatment resources were redirected to combat the pandemic. Since 2010, new HIV infections have declined by more than 31% globally. And, of the estimated 37.7 million people currently living with HIV, more than 28.2 million of them are on antiretroviral therapy, reducing the chances of infecting others and helping them live heathier, longer lives. This is all good news. But global goals to reduce — and end — HIV are fast approaching. The Joint United Nations Programme on HIV/AIDS (UNAIDS) aims to diagnose 95% of all HIV-positive patients, provide antiretroviral therapy for 95% of those diagnosed and achieve viral suppression for 95% of those treated and end new HIV infections by 2030. Yet, an estimated 16% of HIV-positive people globally still don’t know their status. This must change. As an important first step, we must re-engage as a global health community to quickly expand access to HIV testing and treatment outside of traditional healthcare settings, especially for key populations.